ÂÜÀòÂÒÂ×

Ajinkya Inamdar currently serves as Senior Director at BioNTech SE, overseeing the GMS Strategy for Infectious and Oncology Vaccines, including various vaccine portfolios such as BNT163, BNT164, BNT165, and others. With a background in global safety strategy and risk management at companies like Janssen Pharmaceutical and Novartis Oncology, Ajinkya brings extensive experience in clinical development and pharmacovigilance. Ajinkya holds a Master's Degree in Cell/Cellular and Molecular Biology, an MBA in Biotechnology, and a medical degree in Medicine and Surgery.